Meta-Analysis
Copyright ©The Author(s) 2019.
World J Diabetes. May 15, 2019; 10(5): 311-323
Published online May 15, 2019. doi: 10.4239/wjd.v10.i5.311
Table 2 Quality assessment of the included studies
AuthorSénéchal et al[35], 2012Lu et al[18], 2013Poggiogalle et al[36], 2016Ma et al[37], 2016Xiao et al[38], 2017Kang et al[39], 2017Aubertin- Leheudre et al[40], 2017Park et al[41], 2018Scott et al[46], 2018Kreidieh et al[42], 2018Khazem et al[43], 2018
Selection
Represents cases with independent validation11111111111
Cases are consecutive or obviously representative11111111111
Controls from the community11111111111
Controls have no history of sarcopenic obesity11111111111
Comparability
Controls are comparable for the most important factors11111111111
Control for any additional factor00100101000
Ascertainment of exposure
Secured record or structured interview where blind to/control status11110111111
Same method of ascertainment for cases and controls11111111111
Cases and controls have completed follow up00010000100
Total score77886878877